Abstract
The development of new genetic medicines to treat sickle cell disease highlights the need for greater collaboration between researchers and people with lived experiences. Drawing on the adage "Nothing about us, without us," we call for increased investments in community advocacy and engagement.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have